Immediate Impact
57 standout
Citing Papers
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
2024 Standout
Works of J Stříteský being referenced
Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| J Stříteský | 97 | 47 | 85 | 27 | 235 | |
| Hee Won Cho | 60 | 89 | 35 | 31 | 271 | |
| B. Monica | 47 | 80 | 43 | 29 | 279 | |
| Pei‐Chi Kao | 29 | 72 | 28 | 26 | 220 | |
| Anja Ernst | 85 | 91 | 25 | 27 | 295 | |
| Shiyuan Zhou | 32 | 52 | 23 | 32 | 249 | |
| Hanjin Yang | 22 | 47 | 51 | 21 | 227 | |
| J. Wohlschläger | 23 | 43 | 50 | 22 | 280 | |
| Marta Romero-Gutiérrez | 87 | 20 | 100 | 23 | 250 | |
| Özgür Mehtap | 54 | 66 | 41 | 34 | 247 | |
| Ahmed A. Abdel-Kader | 49 | 34 | 88 | 23 | 278 |
All Works
Login with ORCID to disown or claim papers
Loading papers...